XML 51 R39.htm IDEA: XBRL DOCUMENT v3.25.1

COMMON EQUITY (Tables)

3 Months Ended

Mar. 31, 2025

Equity [Abstract]

Schedule of stock-based compensation awards granted

During the three months ended March 31, 2025, the Compensation Committee of our Board of Directors awarded the following stock-based compensation to our directors, officers, and certain other key employees:

Award Type						Number of Awards
Stock options (1)						231,024
Restricted shares (2)						79,170
Performance units						185,945

(1)Stock options awarded had a weighted-average exercise price of $94.55 and a weighted-average grant date fair value of $18.23 per option.

(2)Restricted shares awarded had a weighted-average grant date fair value of $94.55 per share.

Schedule of Common Stock Outstanding Roll Forward

We had the following changes to our outstanding common stock during the three months ended March 31, 2025 and 2024:

						Three Months Ended March 31, 2025						Three Months Ended March 31, 2024
Common stock shares outstanding at beginning of period						317,680,855						315,434,531
Shares issued:
At-the-market offering program						977,824						—
Stock-based compensation						342,711						142,178
401(k)						43,300						124,300
Stock investment plan						88,811						121,578
Common stock shares outstanding at end of period						319,133,501						315,822,587

Schedule of Earnings Per Share, Basic and Diluted

The following table shows the computation of our basic and diluted EPS for the three months ended March 31, 2025 and 2024:

(in millions)						Three Months Ended March 31, 2025						Three Months Ended March 31, 2024
Numerator:
Net income attributed to common shareholders						$	724.2					$	622.3
Denominator:
Weighted average basic shares outstanding						318.2						315.6
Dilutive effect of stock-based compensation awards						0.5						0.3
Dilutive effect of convertible senior notes						0.6						—
Weighted average diluted shares						319.3						315.9
Basic EPS						$	2.28					$	1.97
Diluted EPS						$	2.27					$	1.97

X

- References

No definition available.

+ Details

Name:	us-gaap_EquityAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the change in common stock outstanding.

+ References

No definition available.

+ Details

Name:	us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482662/260-10-50-1

+ Details

Name:	us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the number of equity awards granted during the period, including the weighted-average grant-date fair value and the weighted-average exercise price per award.

+ References

No definition available.

+ Details

Name:	wec_ShareBasedCompensationArrangementByShareBasedPaymentAwardGrantedinPeriodTableTextBlock
Namespace Prefix:	wec_
Data Type:	dtr-types1:textBlockItemType
Balance Type:	na
Period Type:	duration